U.S. Markets closed

Momenta Pharmaceuticals, Inc. (MNTA)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.75-0.25 (-1.67%)
At close: 4:00PM EDT
People also watch
ALNYACORNBIXMDCOVNDA
  • Haters back. Feel better now.
  • MNTA is same up and down with MDCO usually.
  • Where are all the Haters? Did the FDA poop on itself? Worried now......
  • From NVS earnings release. Sandoz net sales were USD 2.4 billion (-1%, +1% cc) in the first quarter, as volume growth of 9 percentage points was offset by 8 percentage points of price erosion. Global sales of Biopharmaceuticals (including biosimilars, biopharmaceutical contract manufacturing and Glatopa) grew +30% (cc) to USD 274 million, driven by strong performance of Zarxio (filgrastim) and Glatopa 20mg in the US.
  • Another one off quarter coming. The payment from CSL will make the numbers look good, but they are far from solid and recurring. The delay ,due to the Pfizer fill finish fiasco, hurts on many different fronts. The biggest will be if another competitor can release a 40 mg copaxone copy first. The second will be to restrict Momenta from buying in to a larger share of the CSL deal, the longer the delay the worst off for Momenta.
  • Amph, Mnta, both are low. But still is not the time to buy. MDCO looks good!
  • I cannot give you the formula for success, http://dataunion.tistory.com/2598

    Momenta Pharmaceuticals NASDAQ : MNTA Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0 In other words, the correlation coefficient of the other stocks
    dataunion.tistory.com
  • Very difficult to see MNTA not making a big run north. I started receiving notifications from awesome-STOCKS the other week and so far they have presented interesting new trade ideas.
  • Amphastar lawsuit against Momenta, back on. Bad news keeps coming.
  • In researching how long it take to comply with a warning letter the average seams to be 17months and the shortest about 5 months. How long will it take is anybody's guess. but it has been about 7 months since the deficiencies were pointed out.
  • cracks in supply chain, for 40 mg Glatopa to keep FDA saying not now to ANDA. look for a pullback in price.. Helps the competition out big. time. Nothing MNTA can do.
  • Who says MNTA isn't poised for potentially massive upward movement? How can it with performance % (year to date) sitting at 6.64%? check out awesom-eSTOCKS, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • Turd
  • It will open $9 tomorrow
  • Time to Sell Short now
  • How long they can support, this FDA news will take it down to Penny
  • Can we call it FDA death warrant?
  • Sell Short
  • Great earnings and the stock crashes ??? What's up ?
  • Buying opportunity for long term investors